Skip to main content
logo
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.30
-0.36 (-4.16%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2010 - 2019
Small Molecule Drugs
67.64M
Log In
Log In
Log In
Log In
Upgrade
Small Molecule Drugs Growth
-14.61%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is October - September.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202010 - 2019
Period Ending
Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2010 - 2019
United States
67.64M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-14.61%
Log In
Log In
Log In
Log In
Upgrade